GGrantIndex
← Leaderboards

Paul Joseph Brennan

International Agency For Res On Cancer

Google Scholar ↗PubMed ↗ORCID ↗
$16,689,806
Attributed
$19,952,072
Total exposure
12
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.1M · FY2005–24
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$32,764,935 · 13

By mechanism

U19$17,316,834 · 4
R01$6,918,251 · 2
U01$6,731,556 · 2
OT2$1,345,330 · 1
R03$452,964 · 4

Top collaborators

Most similar at International Agency For Res On Cancer

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsCancer RiskCancer EtiologySamplingMalignant Neoplasm Of LungBaseCohortVariantGeneticSmokingEuropeanCase ControlCollaborationsRisk FactorsDiagnosticScreeningBiological MarkersSiteDiagnosisGenotypePathway InteractionsPredispositionBlood SpecimenInternational

Grant awards (54)

PROMINENT - IARC$502,922
OT2 · FY2024 · CA · contact PI
PROMINENT - IARC$450,879
OT2 · FY2023 · CA · contact PI
Integrative analysis of lung cancer etiology and risk$2,234,679
U19 · FY2022 · CA
Biomarkers of lung cancer risk$508,311
U19 · FY2022 · CA · contact PI
PROMINENT - IARC$391,529
OT2 · FY2022 · CA · contact PI
Admin-Core-001$228,309
U19 · FY2022 · CA
Integrative analysis of lung cancer etiology and risk$2,334,007
U19 · FY2021 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$706,129
R01 · FY2021 · DE · contact PI
Biomarkers of lung cancer risk$533,833
U19 · FY2021 · CA · contact PI
Admin-Core-001$238,989
U19 · FY2021 · CA
Admin-Core-001$228,106
U19 · FY2021 · CA
Administrative Supplement: Integrative analysis of lung cancer etiology and risk$228,106
U19 · FY2021 · CA
Integrative analysis of lung cancer etiology and risk$2,605,399
U19 · FY2020 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$613,147
R01 · FY2020 · DE · contact PI
Biomarkers of lung cancer risk$595,611
U19 · FY2020 · CA · contact PI
Admin-Core-001$298,234
U19 · FY2020 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$46,718
R01 · FY2020 · DE · contact PI
Integrative analysis of lung cancer etiology and risk$2,306,176
U19 · FY2019 · CA
Biomarkers of lung cancer risk$636,123
U19 · FY2019 · CA · contact PI
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$631,228
R01 · FY2019 · DE · contact PI
Admin-Core-001$229,912
U19 · FY2019 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$630,189
R01 · FY2018 · DE · contact PI
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers$443,239
U01 · FY2018 · CA · contact PI
Research Supplements to Promote Sharing Data in Cancer Epidemiology Studies$147,830
U19 · FY2018 · CA
Integrative analysis of lung cancer etiology and risk$2,783,512
U19 · FY2017 · CA
Biomarkers of lung cancer risk$767,839
U19 · FY2017 · CA · contact PI
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$650,254
R01 · FY2017 · DE · contact PI
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers$466,874
U01 · FY2017 · CA · contact PI
Admin-Core-001$212,658
U19 · FY2017 · CA
Integrative analysis of lung cancer etiology and risk$173,154
U19 · FY2017 · CA
Biomarkers of lung cancer risk$26,046
U19 · FY2017 · CA · contact PI
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers$451,197
U01 · FY2016 · CA · contact PI
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers$483,879
U01 · FY2015 · CA · contact PI
One-carbon metabolism biomarkers and lung cancer risk$24,973
U01 · FY2015 · CA · contact PI
One-carbon metabolism biomarkers and lung cancer risk$771,081
U01 · FY2014 · CA · contact PI
One-carbon metabolism biomarkers and lung cancer risk$673,248
U01 · FY2013 · CA · contact PI
One-carbon metabolism biomarkers and lung cancer risk$1,665,211
U01 · FY2012 · CA · contact PI
One-carbon metabolism biomarkers and lung cancer risk$1,751,854
U01 · FY2011 · CA · contact PI
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS$450,691
R01 · FY2010 · CA · contact PI
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS$457,747
R01 · FY2009 · CA · contact PI
International Lung Cancer Consortium: Pooled Analysis of Genetic Determinants of$56,950
R03 · FY2009 · CA · contact PI
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS$454,425
R01 · FY2008 · CA · contact PI
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS$400,000
R01 · FY2008 · CA · contact PI
International Lung Cancer Consortium: Pooled Analysis of Genetic Determinants of$56,950
R03 · FY2008 · CA · contact PI
GENETICS OF TOBACCO AND ALCOHOL RELATED CANCERS$468,509
R01 · FY2007 · CA · contact PI
Pilot for a Multicenter Case-Control Study of Pancreatic Cancer in a High Risk r*$55,104
R03 · FY2007 · CA · contact PI
Pilot for a Multicenter Case-Control Study of Pancreatic Cancer in a High Risk r*$56,350
R03 · FY2006 · CA · contact PI
International Lung Cancer Consortium: Pooled analysis o*$55,514
R03 · FY2006 · CA · contact PI
Genetics of Tobacco and Alcohol Related Cancers$429,672
R01 · FY2005 · CA
International Lung Cancer Consortium: Pooled analysis o*$57,366
R03 · FY2005 · CA
Genetics of Tobacco and Alcohol Related Cancers$516,278
R01 · FY2004 · CA
Multicentric Pooled Analysis of Second Primary Cancer$57,988
R03 · FY2004 · CA
Genetics of Tobacco and Alcohol Related Cancers$463,264
R01 · FY2003 · CA
Multicentric Pooled Analysis of Second Primary Cancer$56,742
R03 · FY2003 · CA